Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Emory University
Emory University
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Roger Williams Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Research UK
Georgetown University